COMMUNIQUÉS West-GlobeNewswire

Catalyst Pharmaceuticals Announces Its Support of Spinal Muscular Atrophy Awareness Month
01/08/2019
CORAL GABLES, Fla., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-105
01/08/2019
-ET-105 assigned Prescription Drug User Fee Act (PDUFA) target action date of March 17, 2020 DEER PARK, Ill., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical [...]
Alder BioPharmaceuticals® to Present at Canaccord Genuity 39th Annual Growth Conference
01/08/2019
BOTHELL, Wash., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Iterum Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference
01/08/2019
DUBLIN, Ireland and CHICAGO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat [...]
Intellia Therapeutics Announces Second Quarter 2019 Financial Results and Company Update
01/08/2019
NTLA-2001: Intends to submit an investigational new drug application in mid-2020 for lead in vivo program for the treatment of transthyretin amyloidosis On track to nominate first engineered cell therapy development [...]
Kaleido Biosciences Reports Second Quarter 2019 Financial Results and Provides Corporate Update
01/08/2019
LEXINGTON, Mass., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the potential of the microbiome organ to [...]
Repligen Reports Second Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance
01/08/2019
Reports record quarterly revenue of $70.7 million, representing 48% year-over-year growth and 46% organic growth Raises revenue guidance to $264-$268 million for full year 2019, representing 29%-31% organic growth [...]
New Executive Team Announced at Adaptimmune
01/08/2019
- Adrian Rawcliffe to assume CEO role from September 1, 2019 - - John Lunger promoted to Chief Patient Supply Officer from August 1, 2019, as Adaptimmune gears up for commercial delivery of products to patients – - [...]
Resignation of JSC Olainfarm member of the Management Board
01/08/2019
JSC Olainfarm has received the letter of resignation from Martins Tambaks whereby he steps down from his duties as a member of the Management Board as of 31 July 2019. JSC Olainfarm Management Board continues its work [...]
Adaptimmune Reports Second Quarter 2019 Financial Results and Business Update
01/08/2019
- Started SPEARHEAD-1 clinical trial with ADP-A2M4 in synovial sarcoma and MRCLS patients – - Started low-dose radiation sub-study with ADP-A2M4 with the MD Anderson Cancer Center - - Started SURPASS trial – the first [...]
Calithera Biosciences to Report Second Quarter 2019 Financial Results on Thursday, August 8, 2019
01/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the [...]
Summit Therapeutics to Present at the Canaccord Genuity Growth Conference
01/08/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics to Present at the Canaccord Genuity Growth Conference Oxford, UK, and Cambridge, MA, US, 1 August 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM [...]
Avadel Pharmaceuticals Further Strengthens Clinical and Medical Team
01/08/2019
Appoints Courtney Wells as Vice President, Clinical Operations; and David Seiden, M.D., as Senior Medical Director, Clinical Development and Medical Affairs DUBLIN, Ireland, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Avadel [...]
Aclaris Therapeutics to Announce Second Quarter 2019 Financial Results on August 8, 2019
01/08/2019
WAYNE, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory and dermatological diseases, today announced it will [...]
Agios Reports Business Highlights and Second Quarter 2019 Financial Results
01/08/2019
Strong Topline Performance for IDH Inhibitors: TIBSOVO ® Net Revenue Increased 50% from Q1 2019 to $13.7M; IDHIFA ® Royalty Increased to $2.7M Achieved Important Expansion Opportunities for TIBSOVO ® Including sNDA [...]
RTI Surgical® Announces Second Quarter 2019 Results
01/08/2019
Record Revenue Driven by Strong Growth Across Global Spine and OEM Franchises Amplified by Addition of coflex ® Interlaminar Stabilization ® Device DEERFIELD, Ill., Aug. 01, 2019 (GLOBE NEWSWIRE) -- RTI Surgical [...]
Microbix Provides Bioreactor Update
01/08/2019
Largest Customer Confirms Conversion Timetable & Provides Full-Scale Order TORONTO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and [...]
Akorn Provides Preliminary Second Quarter 2019 Results
01/08/2019
LAKE FOREST, Ill., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced its preliminary financial results for the second quarter of 2019. [...]
Recro Pharma to Report Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019
01/08/2019
Conference Call and Webcast Scheduled for Thursday, August 8, 2019 at 8:00 a.m. ET MALVERN, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a pharmaceutical company with a high-performing, [...]

Pages